Fortune Business Insights has announced the release of a market assessment report on "Global Thoracic Outlet Syndrome (TOS) Market Size, Share, Trend Analysis Report, By Type, By Processing, By Distribution Channel, Market Outlook and Industry Analysis 2034."
Fortune Business Insights Report has released its latest report on "Thoracic Outlet Syndrome (TOS) Market Size 2026." The report provides a detailed analysis of market trends, key growth drivers, competitive landscape, and regional insights. The report includes market size (value and volume), CAGR forecasts, and emerging opportunities to help companies identify growth areas and build effective strategies. Backed by data-driven insights and future outlook, this research is a valuable resource for companies looking to stay competitive and capitalize on market potential.
The global thoracic outlet syndrome (TOS) market size was valued at USD 212.2 million in 2024. The market is projected to grow from USD 227.4 million in 2025 to USD 337.8 million by 2032, exhibiting a CAGR of 5.82% during the forecast period.
Get a Sample Research PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/114374
Latest FDA Approval
The FDA has approved several AI-enabled medical devices that are essential to smart hospital infrastructure, including advanced radiology systems such as Fujifilm's ECHELON Synergy MRI and Shanghai United Film's uMI Panvivo, enhancing diagnostic accuracy and workflow automation.
To streamline the approval process and ensure ongoing safety without repeat marketing applications, the FDA has finalized guidance on changes to AI-powered devices through proactive change control plans (PCCPs).
The major Thoracic Outlet Syndrome (TOS) Market manufacturers profiled in the market report are:
The rising prevalence of the disease worldwide and the increasing number of awareness programs are shifting the focus toward early diagnosis and conservative treatment. Thus contributing toward global market growth.
Market Trends
driver:
The global Thoracic Outlet Syndrome (TOS) Market is driven by the introduction of new antibiotics and advancements in surgical interventions, which together are improving patient outcomes and fueling the market growth. Rise in risk factors such as diabetes, obesity, and immunocompromised states are further contributing to the rising incidence worldwide.